About Penta
Who we are
Our Strategy
Our Network
Working Groups
Penta Foundation
Our Staff
Diversity and Inclusion
Annual reports
Our Activities
News & Webinars
News
Press center
Penta Newsletter
Stories
Scientific Views
Penta Aperitivo Webinars
Publications
Contact us
Work with us
Vacancies
Calls for service
PentaTr@ining
Archivio
Advancing the delivery of HIV Care
COVID-19: the neglected importance of thermostable vaccines
“Because we all have to grow up”: supporting adolescents in Uganda to develop core competencies to transition towards managing their HIV more independently
ODYSSEY team at Radboud receives the RIHS Societal Award 2020
ZIKAHOST study shares findings on genetic predisposition to typical ZIKA effects at SEIP 2021
Sharing our understanding of the immune response of children living with HIV
DOLUTEGRAVIR-BASED ART IS SUPERIOR TO NNRTI/PI- BASED ART IN CHILDREN AND ADOLESCENTS
GAP-f webinar on Best practices in clinical research for the development of paediatric formulations
ODYSSEY trial finds new drug is better for treating children living with HIV
International Workshop on HIV Pediatrics now accepting abstracts!
Johnson & Johnson has planned trials of its vaccine that will include infants.